articleLeukemiaMar 11, 2019Closed access

Outcomes of patients with multiple myeloma refractory to CD38-targeted monoclonal antibody therapy

UHUjjawal H. GandhiRFRobert F. CornellALArjun LakshmanZGZhubin GahvariEMElizabeth McGehee

Vanderbilt University Medical Center · Mayo Clinic in Arizona · +15 more institutions

PubMed
Indexed incrossrefpubmed

Abstract

No abstract available for this paper.

Citation impact

614
total citations
FWCI
45.74
Percentile
100%
References
27
Citations per year

Authors

29

Topics & keywords

Topics
Keywords
  • Daratumumab
  • Carfilzomib
  • Medicine
  • Refractory (planetary science)
  • Internal medicine
  • Regimen
  • Population
  • CD38
UN Sustainable Development Goals
  • No poverty
No related works found for this paper.

Funding